中国药企出海依旧任重道远在国内A股市场,恒瑞医药被称为“药茅”。一是3500亿元左右的市值,让其成为几乎每一个打算购买医药股的股民绕不开的选择。二是产品使用量相当之大。药智数据显示,2016—2023年,恒瑞销售额前十名的品种均突破了50亿元大关,前三名国内公立医疗机构销售额更是超过百亿元。如今,这家“巨无霸企业”正式登陆港股。5月23日,恒瑞医药港股首日挂牌上市,首秀大涨约30%,获454.85...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.